MUMBAI, India--(BUSINESS WIRE)--Ideal Cures Private Limited is pleased to announce the addition of a fourth manufacturing location at Sikkim in India for supply of its best-in-class products for not only the pharmaceutical and allied industries in the region, but also its expanding customer base globally.
Ideal Cures, the first film coating company in the world with all its plants EXCiPACT™ certified, is all set to bring its latest facility, which is presently under construction, on line for supply to the Industry in the first quarter of 2017.
This state-of-the art cGMP facility will have the latest technologies implemented in its manufacturing area and will be certified like the other plants to give Ideal Cures the most robust business continuity plan in its business.
Suresh Pareek, Managing Director, said “Our business is customer centric and I am pleased to share with you that our customers who have their plants in Sikkim are extremely happy to see that availability of coating material will be faster. Customers agree that it is easier to work with a supplier who will literally provide sales and services at your door step making lead times and transportation times seem like non-events”.
Dr. Kamlesh Oza, President Global Business Development adds, “Ideal Cures is walking the talk with this significant strategic investment to show solidarity and unparalleled commitment to its customers in the region and globally”.
About IDEAL CURES:
Ideal Cures Private Limited has a global reach with offices in the USA, Italy, Spain, Turkey and Israel. It has three EXCiPACT™ certified cGMP manufacturing plants providing world-class support to pharmaceutical organizations globally. With over 11 patents in India and many more pending grant, the company is determined to bring new coating products and technologies to the market. Ideal Cures. is perceived as a preferred supplier for film coating systems by the Pharmaceutical Industry, which offers them superior technical services and support with competitive prices. The company has spent over a decade and half in its relentless pursuit of excellence in providing tailor made excipients and coating solutions for solid dosage forms. The product range of Ideal Cures comprises Ready-to-use Film Coating Systems, Modified Release Technologies, Acrylic Pharma Polymers to Extended Cooling Boosters and Neutral Spheres.
This information was brought to you by Cision http://news.cision.com